Virotherapie: Entwicklung rekombinanter Negativ-Stran RNA Vektoren auf Basis des Masern Virus (MV) zur onkolytischen Therapie des Kolonkarzinoms

• Applicant: Professor Guy Ungerechts, Ph.D.
• Subject Area: Gastroenterology
• Term: from 2005 to 2008
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 13737878

• Final Report Year: 2008

Final Report Abstract

No abstract available

Publications

• Targeted and armed Measles Viruses for oncolytic therapy. Cold Spring Harbor Meeting, USA, 2005
  Guy Ungerechts
  
• Targeted and armed Measles Viruses for oncolytic therapy. American Society for Virology, Madison, USA, 2006
  Guy Ungerechts
  
• Targeted, armed and stealth Measles Viruse. Siebens Conference, Rochester, USA, 2006
  Guy Ungerechts
  
• "An Immunocompetent Murine Model for Oncolysis with an Armed and Targeted Measles Virus," Molecular Therapy 15(11): 1991-1997 (2007)
  Ungerechts, G., C. Springfeld, M. E. Frenzke, J. Lampe, W. B. Parker, E. J. Sorscher, et al.
  
• "Lymphoma chemovirotherapy: CD20-targeted and convertasearmed measles virus can synergize with fludarabine," Cancer Research. 67(22): 10939-10947 (2007)
  Ungerechts, G., C. Springfeld, M. Frenzke, J. Lampe, P. Johnson, W. B. Parker, et al.
  
• Lymphoma chemovirotherapy using a CD20-targeted Measles Virus locally activating fludarabine phosphate. American Society for Gene Therapy, Seattle, USA, 2007
  Guy Ungerechts
  
• Lymphoma chemovirotherapy using a CD20-targeted Measles Virus locally activating fludarabine phosphate. Oncolytic Virus Meeting, Scottsdale, USA, 2007
  Guy Ungerechts
  
• “Lymphoma chemovirotherapy using a CD20-targeted Measles Virus locally activating fludarabine phosphate. American Society for Virology, Corvallis, USA, 2007
  Guy Ungerechts
  
• An oncolytic measles virus with thtargeted envelope of another morbillivirus: escape from neutralizing antibodies. American Society for Gene Therapy, Boston, USA, 2008
  Guy Ungerechts